Blood Glucose Monitoring System Companies Dynamics

The Blood Glucose Monitoring System Companies was estimated at USD 13.71 billion in 2023 and is anticipated to reach USD 24.11 billion by 2030, expanding at a CAGR of 8.4%.

Global Blood Glucose Monitoring System Companies, By Product BasedOn product, the global Blood Glucose Monitoring System Companies is segmented into selfmonitoringblood glucose (SMBG) systems, and continuous and glucose monitoring (CGM) systems. Although SMBG systems still have a wide market penetration due to their low-cost, they are slowly being replaced by CGM systems, which present real-time glucose data and minimize blood specimen collection. The market is driven by:

Increasing Diabetes Prevalence: The worldwide epidemic of diabetes, specifically type 2 diabetes, is one of the key factors driving growth.

Trucking Technology: This includes innovations such as sensor technology, data analytics, and connectivity that are rapidly evolving.

Rising Health Care Spending: Both governments and private payers are spending more on diabetes care and access to monitoring devices.

Education: Public health campaigns and educational initiatives are creating awareness around the need of regular glucose monitoring.

Request for free sample: https://www.maximizemarketresearch.com/request-sample/263715/ 

Competitive Landscape

The Blood Glucose Monitoring System Companies Industry is highly competitive, with numerous global and regional companies competing for market share. The report focuses on the following key players:

Global
1. Roche Diagnostics ( Basel, Switzerland)
2. Abbott Laboratories (Abbott Park, Illinois, USA)
3. Medtronic (Dublin, Ireland)
4. Dexcom (San Diego, California, USA)
5. Ascensia Diabetes Care (Basel, Switzerland)
North America
1. LifeScan (Wayne, Pennsylvania, USA)
2. Becton, Dickinson and Company (BD) (Franklin Lakes, New Jersey, USA)
3. AgaMatrix ( Salem, New Hampshire, USA)

Europe
1. Ypsomed ( Burgdorf, Switzerland)

Asia Pacific
1. Sinocare Inc. ( Changsha, China)
2. Arkray Inc. ( Kyoto, Japan)
3. Terumo Corporation ( Tokyo, Japan)
4. Bioptik Technology Inc. ( Taichung City, Taiwan)
5. Omron Healthcare ( Kyoto, Japan)
6. Arkray Inc. ( Kyoto, Japan )
7. Terumo Corporation ( Tokyo, Japan )

Segments Covered:

by Product

Self-Monitoring Blood Glucose Systems
Blood Glucose meters
Testing strips
Lancets & Lancing Devices
Continuous Glucose Monitoring Systems
Sensors
Transmitters
Receivers

by Testing Site

Fingertip testing
Alternate Site Testing

by Patient Care Setting

Self/Home Care
Hospital & Clinics

by Application Type

2 Diabetes
Type 1 Diabetes
Gestational Diabetes

Request for free sample: https://www.maximizemarketresearch.com/request-sample/263715/ 

About Us

Maximize Market Research has also worked with over 600 clients across various industries. Data scientists have only been interested in growth for most of their life, and frankly, that’s the reason we partner to so many of the Fortune 500 companies. Vibrant ( https://www.vibrantinfo.com/ )IT IT & telecom, chemical, food & beverage, aerospace & defense, healthcare etc.

Contact US

MAXIMIZE MARKET RESEARCH PVT. LTD.

Pune Banglore Highway, Narhe

India. 411041 Pune, Maharashtra 411041.

+91 9607365656